These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Modern management of heart failure. Stevenson LW. Hosp Pract (1995); 1996 Mar 15; 31(3):103-6,109-10. PubMed ID: 8595996 [Abstract] [Full Text] [Related]
26. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure. Frigerio M, Gronda EG, Mangiavacchi M, Andreuzzi B, Colombo T, De Vita C, Oliva F, Quaini E, Pellegrini A. J Heart Lung Transplant; 1997 Feb 15; 16(2):160-8. PubMed ID: 9059927 [Abstract] [Full Text] [Related]
27. [Optimal approach to the treatment of atrial fibrillation in patients with chronic heart failure]. Abuladze GV, Burdiashvili BSh, Dzhshi IM, Narsiia EV, Kantariia DA. Georgian Med News; 2005 Feb 15; (124-125):44-6. PubMed ID: 16148376 [Abstract] [Full Text] [Related]
29. Management of cardiac complications in patients with thalassemia major. Vecchio C, Derchi G. Semin Hematol; 1995 Oct 15; 32(4):288-96. PubMed ID: 8560286 [No Abstract] [Full Text] [Related]
30. Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Chen JM, Russo MJ, Hammond KM, Mancini DM, Kherani AR, Fal JM, Mazzeo PA, Pinney SP, Edwards NM, Naka Y. Ann Thorac Surg; 2005 Jul 15; 80(1):224-8. PubMed ID: 15975371 [Abstract] [Full Text] [Related]
31. The effect of treatment on the presence of abnormal heart sounds in emergency department patients with heart failure. Collins SP, Lindsell CJ, Peacock WF, Hedger VD, Storrow AB. Am J Emerg Med; 2006 Jan 15; 24(1):25-32. PubMed ID: 16338505 [Abstract] [Full Text] [Related]
34. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status? Winkel E, Kao W, Fisher SG, Heroux AL, Johnson MR, Costanzo MR. J Heart Lung Transplant; 1998 Aug 15; 17(8):809-16. PubMed ID: 9730431 [Abstract] [Full Text] [Related]
35. Intensity and focus of heart failure disease management after hospital discharge. Shah MR, Flavell CM, Weintraub JR, Young MA, Hasselblad V, Fang JC, Nohria A, Lewis EF, Givertz MM, Mudge G, Stevenson LW. Am Heart J; 2005 Apr 15; 149(4):715-21. PubMed ID: 15990758 [Abstract] [Full Text] [Related]
36. The tailored medical therapy in patients with advanced heart failure referred for cardiac transplantation. Campana C, Alessandrino G, Striuli L, Agnesina L, Dequarti MC, Ghio S, Scelsi L, Tavazzi L. Transplant Proc; 2008 Apr 15; 40(6):1999-2000. PubMed ID: 18675112 [Abstract] [Full Text] [Related]
37. Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation. Iberer F, Wasler A, Tscheliessnigg K, Petutschnigg B, Auer T, Müller H, Rödl S. J Heart Lung Transplant; 1993 Apr 15; 12(2):173-8. PubMed ID: 8476887 [Abstract] [Full Text] [Related]
38. Management of chronic heart failure: an old disease with a new face. Prendergast HM, Bunney EB. Emerg Med Australas; 2005 Apr 15; 17(2):143-51. PubMed ID: 15796729 [Abstract] [Full Text] [Related]
39. [Digoxin in chronic heart failure and sinus rhythm: is the end of the controversy in sight?]. van Veldhuisen DJ, de Graeff PA, Crijns HJ. Ned Tijdschr Geneeskd; 1997 Mar 08; 141(10):460-4. PubMed ID: 9173285 [Abstract] [Full Text] [Related]